Company / Gross Profit
ENvue Medical, Inc. Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$1.5M
FY2025
5-year range
$167.0K / $1.5M
FY2021-FY2025
Trend
-1.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has fluctuated over the past 10 years, ranging from $98,000 in FY2016 to $2M in FY2024.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +39.9%.
Improved from $167,000 to $2M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +25.1%
- 5-Year CAGR
- +39.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +39.9%, indicating consistent growth.
- In FY2025, gross profit decreased 1.9% year-over-year.
- Peak gross profit was recorded in FY2024.
- Lowest gross profit in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5M | -1.9% |
| FY2024 | $1.5M | +820.4% |
| FY2023 | $167.0K | -78.3% |
| FY2022 | $770.0K | +259.8% |
| FY2021 | $214.0K | -23.8% |
| FY2020 | $281.0K | +75.6% |
| FY2019 | $160.0K | +6.0% |
| FY2018 | $151.0K | +7.1% |
| FY2017 | $141.0K | +43.9% |
| FY2016 | $98.0K | -10.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026